Literature DB >> 16127242

Selective inhibition of inducible nitric oxide synthase attenuates renal ischemia and damage in experimental heatstroke.

Chin-Cheng Lee1, Yi-Yang Lee, Cheng-Kuei Chang, Mao-Tsun Lin.   

Abstract

The aim of the present study was to determine whether the possible occurrence of renal ischemia and damage during heatstroke can be suppressed by prior administration of L-N6-(1-iminoethyl) lysine (L-NIL), a selective inducible nitric oxide synthase (iNOS) inhibitor. Urethane-anesthetized rats were exposed to heat stress (43 degrees C) to induce heatstroke. Control rats were exposed to 24 degrees C. Mean arterial pressure and renal blood flow after the onset of heatstroke both were significantly lower in vehicle-treated heatstroke rats than in normothermic controls. However, both the body temperature and renal damage scores were greater in vehicle-treated heatstroke rats compared with normothermic controls. Plasma nitric oxide (NO), creatinine, and blood urea nitrogen (BUN), as well as the renal immunoreactivity of iNOS and peroxynitrite all were significantly higher in vehicle-treated heatstroke rats compared with their normothermic controls. Pretreatment with L-NIL (3 mg/kg, administered intravenously and immediately at the onset of heat stress) significantly attenuated heatstroke-induced hyperthermia, arterial hypotension, renal ischemia and damage, increased renal levels of immunoreactivity of iNOS and peroxynitrite, and increased plasma levels of NO, creatinine, and BUN. Accordingly, pretreatment with L-NIL significantly improved survival during heatstroke. The results suggest that selective inhibition of iNOS-dependent NO and peroxynitrite formation protects against renal ischemia and damage during heatstroke by reducing hyperthermia and arterial hypotension.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16127242     DOI: 10.1254/jphs.fp0050300

Source DB:  PubMed          Journal:  J Pharmacol Sci        ISSN: 1347-8613            Impact factor:   3.337


  4 in total

1.  Death receptors mediate the adverse effects of febrile-range hyperthermia on the outcome of lipopolysaccharide-induced lung injury.

Authors:  Anne B Lipke; Gustavo Matute-Bello; Raquel Herrero; Venus A Wong; Stephen M Mongovin; Thomas R Martin
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2011-04-22       Impact factor: 5.464

2.  Differences in immunolocalization of Kim-1, RPA-1, and RPA-2 in kidneys of gentamicin-, cisplatin-, and valproic acid-treated rats: potential role of iNOS and nitrotyrosine.

Authors:  Jun Zhang; Peter L Goering; Parvaneh Espandiari; Martin Shaw; Joseph V Bonventre; Vishal S Vaidya; Ronald P Brown; Joe Keenan; Cormac G Kilty; Nakissa Sadrieh; Joseph P Hanig
Journal:  Toxicol Pathol       Date:  2009-06-17       Impact factor: 1.902

Review 3.  Novel pharmacological approaches to the treatment of renal ischemia-reperfusion injury: a comprehensive review.

Authors:  Prabal K Chatterjee
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2007-09-22       Impact factor: 3.000

4.  Suppression of peripheral sympathetic activity underlies protease-activated receptor 2-mediated hypotension.

Authors:  Young-Hwan Kim; Duck-Sun Ahn; Ji-Hyun Joeng; Seungsoo Chung
Journal:  Korean J Physiol Pharmacol       Date:  2014-12-30       Impact factor: 2.016

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.